News & Updates
Filter by Specialty:
High intake of macronutrients ups ADHD risk in children
Children who have lower intakes of vitamins and mineral and higher intakes of macronutrients are more likely to have attention deficit hyperactivity disorder (ADHD), suggests an Egypt study.
High intake of macronutrients ups ADHD risk in children
26 Feb 2024Bacterial codetection tied to better outcomes in ventilated infants with bronchiolitis
Bacterial respiratory tract infection normally occurs in infants requiring early intubation in the emergency department (ED) for viral bronchiolitis, according to a study. However, respiratory bacterial codetection appears to shorten the duration of mechanical ventilation (MV) and length of stay (LOS) of these patients in the intensive care unit (ICU).
Bacterial codetection tied to better outcomes in ventilated infants with bronchiolitis
25 Feb 2024Methylnaltrexone proves safety in paediatric oncology patients with constipation
Subcutaneous methylnaltrexone is safe to use in children with cancer who have opioid-induced constipation, suggest the results of a study. In addition, this agent stimulates bowel movements in more than a third of paediatric patients.
Methylnaltrexone proves safety in paediatric oncology patients with constipation
24 Feb 2024Children of mothers with AD prone to develop AD, other allergic illness
Children whose mothers have atopic dermatitis (AD) are likely to develop the same disease, while some develop other allergic illness (OAI) first, reports a study. This suggests that not everyone will follow the same sequential pathway.
Children of mothers with AD prone to develop AD, other allergic illness
22 Feb 2024Infliximab, vedolizumab similarly effective as 1L Tx for paediatric IBD
In a study presented at Crohn’s and Colitis Congress 2024, infliximab and vedolizumab were found to have similar effectiveness in achievÂing steroid-free clinical remission (SFCR) and biochemical remission (BR) at 12 months when used as first-line treatment for biologic-naïve paediatric patients with unÂcomplicated mild-to-moderately active inflammatory bowel disease (IBD).